摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Bromomethyl-6,10-dimethyl-triphenylene | 239455-01-7

中文名称
——
中文别名
——
英文名称
2-Bromomethyl-6,10-dimethyl-triphenylene
英文别名
2-(Bromomethyl)-6,10-dimethyltriphenylene
2-Bromomethyl-6,10-dimethyl-triphenylene化学式
CAS
239455-01-7
化学式
C21H17Br
mdl
——
分子量
349.27
InChiKey
IKSCLAVFUNXRFY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    524.4±19.0 °C(Predicted)
  • 密度:
    1.375±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    7
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor
    摘要:
    The HIV-1 Tat protein is a promising target for AIDS therapy, due to its extra-cellular roles against the immune system. From the 2D-NMR structure of Tat, we have designed molecules, called TDS, able to bind to Tat and inhibit HIV-1 replication in vitro. This new family of antivirals is composed of a triphenylene aromatic ring substituted with at least one carbon chain bearing a succinimide group. These ligands are prepared from triphenylene or 2,6, 10-trimethylphenylene in 3-6 steps depending on the target molecule. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.12.095
  • 作为产物:
    描述:
    2,6,10-trimethyltriphenyleneN-溴代丁二酰亚胺(NBS)偶氮二异丁腈过氧化苯甲酰 作用下, 以 四氯化碳 为溶剂, 以40%的产率得到2-Bromomethyl-6,10-dimethyl-triphenylene
    参考文献:
    名称:
    A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor
    摘要:
    The HIV-1 Tat protein is a promising target for AIDS therapy, due to its extra-cellular roles against the immune system. From the 2D-NMR structure of Tat, we have designed molecules, called TDS, able to bind to Tat and inhibit HIV-1 replication in vitro. This new family of antivirals is composed of a triphenylene aromatic ring substituted with at least one carbon chain bearing a succinimide group. These ligands are prepared from triphenylene or 2,6, 10-trimethylphenylene in 3-6 steps depending on the target molecule. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.12.095
点击查看最新优质反应信息